Chronic Hepatitis B Market Report 2026
Download Free Sample Buy Now
Chronic Hepatitis B Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Chronic Hepatitis B Market Report 2026

Global Outlook – By Drug Class (Antivirals, Immune Modulators), By Gender (Male, Female), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Chronic Hepatitis B Market Overview

• Chronic Hepatitis B market size has reached to $3.93 billion in 2025

• Expected to grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 3.7%

• Growth Driver: High Prevalence Of Hepatitis B Infection

• Market Trend: Major Companies Innovate In Chronic Hepatitis B Treatment With Novel Antiviral Therapies And Clinical Trials

• North America was the largest region in 2025.

What Is Covered Under Chronic Hepatitis B Market?

Chronic hepatitis B is a long-term infection with the hepatitis B virus (HBV) lasting over six months, potentially leading to severe liver damage, liver failure, or liver cancer. It is often asymptomatic for years but can be detected through blood tests and managed with antiviral medications and regular monitoring.

The main types of drugs in chronic hepatitis B include antivirals and immunomodulators. Antivirals are medications designed to inhibit the growth and replication of viruses and help manage the chronic hepatitis B condition by reducing the viral load in the liver and slowing liver damage progression. The gender types include male and female, and the distribution channels include hospital pharmacies, drug stores and retail pharmacies, and online providers.

Chronic Hepatitis B Market Global Report 2026 Market Report bar graph

What Is The Chronic Hepatitis B Market Size and Share 2026?

The chronic hepatitis b market size has grown steadily in recent years. It will grow from $3.93 billion in 2025 to $4.1 billion in 2026 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to improved hepatitis B screening programs, expansion of antiviral drug availability, rising awareness of liver disease complications, increased use of nucleos(t)ide analogs, establishment of long-term disease monitoring protocols.

What Is The Chronic Hepatitis B Market Growth Forecast?

The chronic hepatitis b market size is expected to see steady growth in the next few years. It will grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to increasing investments in next-generation HBV therapies, rising demand for finite-duration treatment regimens, expansion of therapeutic vaccine development, growing focus on eliminating viral reservoirs, increased global hepatitis elimination initiatives. Major trends in the forecast period include increasing adoption of long-term antiviral therapies, rising development of functional cure approaches, growing focus on early disease detection and monitoring, expansion of immune-modulating treatment strategies, enhanced patient adherence programs.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Chronic Hepatitis B Market Segmentation

1) By Drug Class: Antivirals, Immune Modulators

2) By Gender: Male, Female

3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

Subsegments:

1) By Antivirals: Nucleos(T) Ide Analogs (Tenofovir, Entecavir), Interferons (Pegylated Interferon)

2) By Immune Modulators: Immune Checkpoint Inhibitors, Therapeutic Vaccines (HBV Vaccines Under Development)

What Is The Driver Of The Chronic Hepatitis B Market?

The high prevalence of chronic hepatitis B infection is expected to propel the growth of the chronic hepatitis B virus market going forward. Hepatitis B is a liver infection brought on by the hepatitis B virus (HBV), which is prevented through vaccination. The increase in hepatitis B infection rates is due to a combination of factors, particularly in low- and middle-income countries, due to low vaccination coverage leading to higher transmission rates as large portions of the population remain unprotected. Rising hepatitis B infection rates can increase demand for diagnostic tests and treatment options. For instance, in June 2024, according to a report published by the Centers for Disease Control and Prevention (CDC), a US-based government agency, increasing global hepatitis B vaccination coverage to 90% and treatment access to 80% could prevent 26 million new infections and 9 million deaths attributable to hepatitis B between 2022 and 2050. In 2022, there were 1.2 million new cases of hepatitis B virus (HBV) infection. Therefore, the high prevalence of hepatitis B infection will drive the chronic hepatitis B virus market.

Key Players In The Global Chronic Hepatitis B Market

Major companies operating in the chronic hepatitis b market are Pfizer Inc., F Hoffmann-La Roche Ltd, Merck & Co Inc, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Dynavax Technologies Corporation, Gilead Sciences Inc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Apotex Corp, Cipla Ltd, Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc, Vir Biotechnology Inc, VBI Vaccines Inc, Shenzhen Hepalink Pharmaceutical Co. Ltd., Accord Healthcare Inc, Par Pharmaceutical Inc, Arrowhead Pharmaceuticals Inc, ViiV Healthcare, Arbutus Biopharma Corporation, Ascentage Pharma, ENYO Pharma, Zydus Pharmaceuticals Inc, Nucorion Pharmaceuticals

Global Chronic Hepatitis B Market Trends and Insights

Major companies operating in the chronic hepatitis B market are focusing on technological advancements such as novel antiviral therapies. Novel antiviral therapies are innovative medications targeting viral infections, especially resistant ones, by inhibiting replication and using advanced delivery systems, with ongoing clinical trials for safety and effectiveness, such as bepirovirsen for chronic hepatitis B. For instance, in February 2024, GSK plc, a UK-based multinational pharmaceutical and biotechnology company that specializes in the research, development, manufacturing, and marketing of a wide range of healthcare products, received the U.S. Food and Drug Administration (FDA) Fast Track designation for bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB). Bepirovirsen is designed to target and degrade the RNA of the hepatitis B virus (HBV), potentially allowing the immune system to regain control over the infection. The drug has demonstrated promising results in Phase IIb trials, specifically the B-Clear and B-Sure studies, where it showed efficacy in reducing hepatitis B surface antigen (HBsAg) levels and achieving sustained viral suppression.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Chronic Hepatitis B Market?

In November 2023, GSK plc, a U.K.-based pharmaceuticals company, acquired exclusive rights to hepatitis B therapy from Janssen Pharmaceuticals for $1 billion. With the rights to JNJ-3989 (also known as ARO-HBV), an antisense oligonucleotide drug, GSK aims to expand its portfolio and strengthen its position in the treatment of chronic hepatitis B by adding a new, potentially valuable therapy to its offerings. Janssen Pharmaceuticals, a Belgium-based subsidiary of Johnson & Johnson, specializes in developing treatments for various serious and complex diseases, including infectious diseases such as chronic hepatitis B.

Regional Outlook

North America was the largest region in the chronic hepatitis B market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Hepatitis B Market?

The chronic hepatitis B market consists of revenues earned by entities by providing services such as diagnostic testing, treatments, liver function monitoring, patient education, and support programs.The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic hepatitis B market also includes sales of medications, interferons, liver transplant medications, diagnostic kits, liver biopsy equipment, and HBV vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Hepatitis B Market Report 2026?

The chronic hepatitis b market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic hepatitis b industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Chronic Hepatitis B Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.1 billion
Revenue Forecast In 2035 $4.74 billion
Growth Rate CAGR of 4.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Class, Gender, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F Hoffmann-La Roche Ltd, Merck & Co Inc, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Dynavax Technologies Corporation, Gilead Sciences Inc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Apotex Corp, Cipla Ltd, Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc, Vir Biotechnology Inc, VBI Vaccines Inc, Shenzhen Hepalink Pharmaceutical Co. Ltd., Accord Healthcare Inc, Par Pharmaceutical Inc, Arrowhead Pharmaceuticals Inc, ViiV Healthcare, Arbutus Biopharma Corporation, Ascentage Pharma, ENYO Pharma, Zydus Pharmaceuticals Inc, Nucorion Pharmaceuticals
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Chronic Hepatitis B Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Chronic Hepatitis B Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Chronic Hepatitis B Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Chronic Hepatitis B Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Long-Term Antiviral Therapies

4.2.2 Rising Development Of Functional Cure Approaches

4.2.3 Growing Focus On Early Disease Detection And Monitoring

4.2.4 Expansion Of Immune-Modulating Treatment Strategies

4.2.5 Enhanced Patient Adherence Programs

5. Chronic Hepatitis B Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Liver Specialty Clinics

5.3 Diagnostic Laboratories

5.4 Public Health Programs

5.5 Retail Pharmacies

6. Chronic Hepatitis B Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Chronic Hepatitis B Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Chronic Hepatitis B PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Chronic Hepatitis B Market Size, Comparisons And Growth Rate Analysis

7.3. Global Chronic Hepatitis B Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Chronic Hepatitis B Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Chronic Hepatitis B Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Chronic Hepatitis B Market Segmentation

9.1. Global Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antivirals, Immune Modulators

9.2. Global Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Male, Female

9.3. Global Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

9.4. Global Chronic Hepatitis B Market, Sub-Segmentation Of Antivirals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nucleos(T) Ide Analogs (Tenofovir, Entecavir), Interferons (Pegylated Interferon)

9.5. Global Chronic Hepatitis B Market, Sub-Segmentation Of Immune Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immune Checkpoint Inhibitors, Therapeutic Vaccines (HBV Vaccines Under Development)

10. Chronic Hepatitis B Market Regional And Country Analysis

10.1. Global Chronic Hepatitis B Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Chronic Hepatitis B Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Chronic Hepatitis B Market

11.1. Asia-Pacific Chronic Hepatitis B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Chronic Hepatitis B Market

12.1. China Chronic Hepatitis B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Chronic Hepatitis B Market

13.1. India Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Chronic Hepatitis B Market

14.1. Japan Chronic Hepatitis B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Chronic Hepatitis B Market

15.1. Australia Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Chronic Hepatitis B Market

16.1. Indonesia Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Chronic Hepatitis B Market

17.1. South Korea Chronic Hepatitis B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Chronic Hepatitis B Market

18.1. Taiwan Chronic Hepatitis B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Chronic Hepatitis B Market

19.1. South East Asia Chronic Hepatitis B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Chronic Hepatitis B Market

20.1. Western Europe Chronic Hepatitis B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Chronic Hepatitis B Market

21.1. UK Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Chronic Hepatitis B Market

22.1. Germany Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Chronic Hepatitis B Market

23.1. France Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Chronic Hepatitis B Market

24.1. Italy Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Chronic Hepatitis B Market

25.1. Spain Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Chronic Hepatitis B Market

26.1. Eastern Europe Chronic Hepatitis B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Chronic Hepatitis B Market

27.1. Russia Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Chronic Hepatitis B Market

28.1. North America Chronic Hepatitis B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Chronic Hepatitis B Market

29.1. USA Chronic Hepatitis B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Chronic Hepatitis B Market

30.1. Canada Chronic Hepatitis B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Chronic Hepatitis B Market

31.1. South America Chronic Hepatitis B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Chronic Hepatitis B Market

32.1. Brazil Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Chronic Hepatitis B Market

33.1. Middle East Chronic Hepatitis B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Chronic Hepatitis B Market

34.1. Africa Chronic Hepatitis B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Chronic Hepatitis B Market, Segmentation By Drug Class, Segmentation By Gender, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Chronic Hepatitis B Market Regulatory and Investment Landscape

36. Chronic Hepatitis B Market Competitive Landscape And Company Profiles

36.1. Chronic Hepatitis B Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Chronic Hepatitis B Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Chronic Hepatitis B Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Chronic Hepatitis B Market Other Major And Innovative Companies

GlaxoSmithKline plc, Dynavax Technologies Corporation, Gilead Sciences Inc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Apotex Corp, Cipla Ltd, Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc, Vir Biotechnology Inc, VBI Vaccines Inc, Shenzhen Hepalink Pharmaceutical Co. Ltd.

38. Global Chronic Hepatitis B Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Chronic Hepatitis B Market

40. Chronic Hepatitis B Market High Potential Countries, Segments and Strategies

40.1 Chronic Hepatitis B Market In 2030 - Countries Offering Most New Opportunities

40.2 Chronic Hepatitis B Market In 2030 - Segments Offering Most New Opportunities

40.3 Chronic Hepatitis B Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Chronic Hepatitis B Market, Overview Of Key Products - Product Examples
  • Table 2: Global Chronic Hepatitis B Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Chronic Hepatitis B Market, Supply Chain Analysis
  • Table 4: Global Chronic Hepatitis B Market, Major Raw Material Providers
  • Table 5: Global Chronic Hepatitis B Market, Major Resource Providers
  • Table 6: Global Chronic Hepatitis B Market, Major Manufacturers (Suppliers)
  • Table 7: Global Chronic Hepatitis B Market, Major Distributors And Channel Partners
  • Table 8: Global Chronic Hepatitis B Market, Key Technologies & Future Trends
  • Table 9: Global Chronic Hepatitis B Market, Major Trends
  • Table 10: Global Chronic Hepatitis B Market, Major End Users
  • Table 11: Global Chronic Hepatitis B Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Chronic Hepatitis B Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Chronic Hepatitis B Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Chronic Hepatitis B Market - TAM, US$ Billion, 2025
  • Table 15: Global Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Chronic Hepatitis B Market, Sub-Segmentation Of Antivirals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Chronic Hepatitis B Market, Sub-Segmentation Of Immune Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Chronic Hepatitis B Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Chronic Hepatitis B Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Chronic Hepatitis B Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Chronic Hepatitis B Market - Company Scoring Matrix
  • Table 96: Pfizer Inc. Financial Performance
  • Table 97: F Hoffmann-La Roche Ltd Financial Performance
  • Table 98: Merck & Co Inc Financial Performance
  • Table 99: Bristol-Myers Squibb Company Financial Performance
  • Table 100: Novartis AG Financial Performance
  • Table 101: Global Chronic Hepatitis B Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Chronic Hepatitis B Market, Competitive Dashboard
  • Table 103: Global Chronic Hepatitis B Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Chronic Hepatitis B Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 105: Global, Chronic Hepatitis B Market Size Gain ($ Billion), Segmentation By Gender, 2025 – 2030
  • Table 106: Global, Chronic Hepatitis B Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Chronic Hepatitis B Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Chronic Hepatitis B Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Chronic Hepatitis B Market, Supply Chain Analysis
  • Figure 4: Global Chronic Hepatitis B Market, Major Raw Material Providers
  • Figure 5: Global Chronic Hepatitis B Market, Major Resource Providers
  • Figure 6: Global Chronic Hepatitis B Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Chronic Hepatitis B Market, Major Distributors And Channel Partners
  • Figure 8: Global Chronic Hepatitis B Market, Key Technologies & Future Trends
  • Figure 9: Global Chronic Hepatitis B Market, Major Trends
  • Figure 10: Global Chronic Hepatitis B Market, Major End Users
  • Figure 11: Global Chronic Hepatitis B Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Chronic Hepatitis B Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Chronic Hepatitis B Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Chronic Hepatitis B Market - TAM, US$ Billion, 2025
  • Figure 15: Global Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Chronic Hepatitis B Market, Sub-Segmentation Of Antivirals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Chronic Hepatitis B Market, Sub-Segmentation Of Immune Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Chronic Hepatitis B Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Chronic Hepatitis B Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Chronic Hepatitis B Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Chronic Hepatitis B Market - Company Scoring Matrix
  • Figure 96: Pfizer Inc. Financial Performance
  • Figure 97: F Hoffmann-La Roche Ltd Financial Performance
  • Figure 98: Merck & Co Inc Financial Performance
  • Figure 99: Bristol-Myers Squibb Company Financial Performance
  • Figure 100: Novartis AG Financial Performance
  • Figure 101: Global Chronic Hepatitis B Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Chronic Hepatitis B Market, Competitive Dashboard
  • Figure 103: Global Chronic Hepatitis B Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Chronic Hepatitis B Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 105: Global, Chronic Hepatitis B Market Size Gain ($ Billion), Segmentation By Gender, 2025 – 2030
  • Figure 106: Global, Chronic Hepatitis B Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Chronic Hepatitis B Market Report 2026 - Global Outlook – By Drug Class (Antivirals, Immune Modulators), By Gender (Male, Female), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online P...

Hepatitis B Virus (HBV) Market Report 2026 - Global Outlook – By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery), By Age Group (Pediatrics, Adults, Seniors), By End User (M...

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Viral Hepatitis Market Report 2026 - Global Outlook – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Diagnosis (Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis), By Treatment (...

Hepatitis Drugs Market Report 2026 - Global Outlook – By Drug Class (Interferon Alphas, HIV NRTIs, Nucleotide Polymerase Or NS5A Inhibitor Combinations, Hepatitis C Protease Or NS5A Inhibitor Combinations, NS5A Inhibitor...

Hepatitis Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Drug Class (Oral Antivirals, Immune Modulators), By Distribution Channel (Hosp...

Hepatitis C Market Report 2026 - Global Outlook – By Type (Chronic Hepatitis C, Acute Hepatitis C), By Diagnosis (Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis), By Distribution Channel (Hospital And Retail P...

Alcoholic Hepatitis Treatment Market Report 2026 - Global Outlook – By Treatment Type (Drug Therapy, Supportive And Nutritional Therapy), By Route Of Administration (Oral, Injectable), By Severity Of Disease (Mild Alcoho...

Frequently Asked Questions

The Chronic Hepatitis B market was valued at $3.93 billion in 2025, increased to $4.1 billion in 2026, and is projected to reach $4.74 billion by 2030.

The global Chronic Hepatitis B market is expected to grow at a CAGR of 3.7% from 2026 to 2035 to reach $4.74 billion by 2035.

Some Key Players in the Chronic Hepatitis B market Include, Pfizer Inc., F Hoffmann-La Roche Ltd, Merck & Co Inc, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Dynavax Technologies Corporation, Gilead Sciences Inc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Apotex Corp, Cipla Ltd, Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc, Vir Biotechnology Inc, VBI Vaccines Inc, Shenzhen Hepalink Pharmaceutical Co. Ltd., Accord Healthcare Inc, Par Pharmaceutical Inc, Arrowhead Pharmaceuticals Inc, ViiV Healthcare, Arbutus Biopharma Corporation, Ascentage Pharma, ENYO Pharma, Zydus Pharmaceuticals Inc, Nucorion Pharmaceuticals .

Major trend in this market includes: Major Companies Innovate In Chronic Hepatitis B Treatment With Novel Antiviral Therapies And Clinical Trials. For further insights on this market. request a sample here

North America was the largest region in the chronic hepatitis B market in 2025. The regions covered in the chronic hepatitis b market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us